• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 CT 容积分割测量转移性肾上腺皮质癌的肿瘤倍增时间。

Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma.

机构信息

Pediatric Oncology Branch, Rare Tumor Initiative, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.

出版信息

Curr Oncol. 2021 Nov 1;28(6):4357-4366. doi: 10.3390/curroncol28060370.

DOI:10.3390/curroncol28060370
PMID:34898541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8628706/
Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy with an overall unfavorable prognosis. Clinicians treating patients with ACC have noted accelerated growth in metastatic liver lesions that requires rapid intervention compared to other metastatic locations. This study measured and compared the growth rates of metastatic ACC lesions in the lungs, liver, and lymph nodes using volumetric segmentation. A total of 12 patients with metastatic ACC (six male; six female) were selected based on their medical history. Computer tomography (CT) exams were retrospectively reviewed and a sampling of ≤5 metastatic lesions per organ were selected for evaluation. Lesions in the liver, lung, and lymph nodes were measured and evaluated by volumetric segmentation. Statistical analyses were performed to compare the volumetric growth rates of the lesions in each organ system. In this cohort, 5/12 had liver lesions, 7/12 had lung lesions, and 5/12 had lymph node lesions. A total of 92 lesions were evaluated and segmented for lesion volumetry. The volume doubling time per organ system was 27 days in the liver, 90 days in the lungs, and 95 days in the lymph nodes. In this series of 12 patients with metastatic ACC, liver lesions showed a faster growth rate than lung or lymph node lesions.

摘要

肾上腺皮质癌(ACC)是一种罕见的恶性肿瘤,总体预后不良。治疗 ACC 患者的临床医生注意到转移性肝病变的生长速度加快,与其他转移部位相比需要迅速干预。本研究使用体积分割测量并比较了肺、肝和淋巴结中转移性 ACC 病变的生长速度。根据病史,共选择了 12 名患有转移性 ACC(6 名男性;6 名女性)的患者。回顾性审查计算机断层扫描(CT)检查,并选择每个器官的≤5 个转移性病变进行评估。通过体积分割测量和评估肝、肺和淋巴结中的病变。进行了统计学分析,以比较每个器官系统中病变的体积增长率。在该队列中,5/12 例有肝病变,7/12 例有肺病变,5/12 例有淋巴结病变。共评估和分割了 92 个病变进行病变体积测量。每个器官系统的体积倍增时间分别为肝脏 27 天、肺部 90 天和淋巴结 95 天。在这一系列 12 名转移性 ACC 患者中,肝病变的生长速度比肺或淋巴结病变快。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93f/8628706/e93956a94d3b/curroncol-28-00370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93f/8628706/a89d1c4338a5/curroncol-28-00370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93f/8628706/8f08f4d0886c/curroncol-28-00370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93f/8628706/e93956a94d3b/curroncol-28-00370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93f/8628706/a89d1c4338a5/curroncol-28-00370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93f/8628706/8f08f4d0886c/curroncol-28-00370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93f/8628706/e93956a94d3b/curroncol-28-00370-g003.jpg

相似文献

1
Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma.使用 CT 容积分割测量转移性肾上腺皮质癌的肿瘤倍增时间。
Curr Oncol. 2021 Nov 1;28(6):4357-4366. doi: 10.3390/curroncol28060370.
2
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.18F-FDG PET/CT 在肾上腺皮质癌患者术后监测中的应用。
Eur J Endocrinol. 2015 Dec;173(6):749-56. doi: 10.1530/EJE-15-0707. Epub 2015 Sep 7.
3
[¹²³I]Iodometomidate imaging in adrenocortical carcinoma.碘莫司他在肾上腺皮质癌中的影像学表现。
J Clin Endocrinol Metab. 2013 Jul;98(7):2755-64. doi: 10.1210/jc.2012-3261. Epub 2013 Apr 22.
4
Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation.寡转移肾上腺皮质癌:影像引导热消融的作用。
Eur Radiol. 2020 Dec;30(12):6958-6964. doi: 10.1007/s00330-020-07019-w. Epub 2020 Jul 3.
5
[An unusual cause of hypertension].[高血压的一种罕见病因]
Ann Cardiol Angeiol (Paris). 2019 Feb;68(1):56-60. doi: 10.1016/j.ancard.2018.08.022. Epub 2018 Oct 2.
6
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.使用(18)F-FDG正电子发射断层扫描评估初治肾上腺皮质癌患者的肿瘤异质性。
Endocrine. 2016 Sep;53(3):791-800. doi: 10.1007/s12020-016-0970-1. Epub 2016 May 2.
7
Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management.肾上腺皮质癌:病理学、基因组学、预后、影像学特征及其对治疗的影响。
Abdom Radiol (NY). 2020 Apr;45(4):945-963. doi: 10.1007/s00261-019-02371-y.
8
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.探讨趋化因子受体 4 作为肾上腺皮质癌患者潜在治疗靶点的研究。
Clin Nucl Med. 2017 Jan;42(1):e29-e34. doi: 10.1097/RLU.0000000000001435.
9
An Interesting Case of Hepatic Adrenocortical Carcinoma.肝肾上腺皮质癌的一个有趣病例
Acta Med Indones. 2018 Jul;50(3):257-259.
10
Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.《分子影像学在肾上腺皮质癌管理中的应用:系统评价》。
Clin Nucl Med. 2016 Aug;41(8):e368-82. doi: 10.1097/RLU.0000000000001112.

引用本文的文献

1
Analysis of factors influencing tumor volume doubling time in hepatocellular carcinoma and its predictive value for progression-free survival.肝细胞癌肿瘤体积倍增时间的影响因素分析及其对无进展生存期的预测价值
Sci Rep. 2025 Jul 16;15(1):25840. doi: 10.1038/s41598-025-06349-3.
2
Surgery for advanced adrenal malignant disease: recommendations based on European Society of Endocrine Surgeons consensus meeting.晚期肾上腺恶性疾病的手术治疗:基于欧洲内分泌外科学会共识会议的建议
Br J Surg. 2024 Jan 3;111(1). doi: 10.1093/bjs/znad266.

本文引用的文献

1
Long-term outcomes in patients with advanced adrenocortical carcinoma after image-guided locoregional ablation or embolization.经影像学引导的局部消融或栓塞治疗后的晚期肾上腺皮质癌患者的长期结局。
Cancer Med. 2021 Apr;10(7):2259-2267. doi: 10.1002/cam4.3740. Epub 2021 Mar 9.
2
Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.肝细胞癌肿瘤体积倍增时间:系统评价和荟萃分析。
Gut. 2021 Feb;70(2):401-407. doi: 10.1136/gutjnl-2020-321040. Epub 2020 May 12.
3
Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma.
伪装成嗜铬细胞瘤的肾上腺皮质癌:一种组织病理学难题。
Endocrinol Diabetes Metab Case Rep. 2020 Jan 8;2020. doi: 10.1530/EDM-19-0147.
4
Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study.无疾病间期和肿瘤功能状态可用于选择肾上腺皮质癌肝转移切除/消融的患者:来自多机构研究的见解。
HPB (Oxford). 2020 Jan;22(1):169-175. doi: 10.1016/j.hpb.2019.07.002. Epub 2019 Aug 22.
5
Natural History of Gastric Cancer: Observational Study of Gastric Cancer Patients Not Treated During Follow-Up.胃癌自然史:未在随访期间治疗的胃癌患者的观察性研究。
Ann Surg Oncol. 2019 Sep;26(9):2905-2911. doi: 10.1245/s10434-019-07455-z. Epub 2019 Jun 12.
6
Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients.实体成分肿瘤倍增时间是非小细胞肺癌患者的一个预后因素。
J Cardiothorac Surg. 2019 Mar 12;14(1):57. doi: 10.1186/s13019-019-0879-x.
7
Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma.米托坦单药治疗晚期肾上腺皮质癌患者。
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1686-1695. doi: 10.1210/jc.2017-02591.
8
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.肿瘤体积倍增时间作为肝细胞癌患者的动态预后标志物
Dig Dis Sci. 2017 Oct;62(10):2923-2931. doi: 10.1007/s10620-017-4708-6. Epub 2017 Aug 16.
9
Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.肾上腺皮质癌肝转移灶切除术后的结局:一项回顾性研究。
BMC Cancer. 2017 Aug 4;17(1):522. doi: 10.1186/s12885-017-3506-z.
10
Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.肺转移瘤的肿瘤体积倍增时间可预测总生存期,并能指导转移性滤泡细胞源性甲状腺癌患者开始多激酶抑制剂治疗。
Cancer. 2017 Aug 1;123(15):2955-2964. doi: 10.1002/cncr.30690. Epub 2017 Apr 3.